Found: 13
Select item for more details and to access through your institution.
Hepatic angiomyolipoma with minimal fat, mimicking hepatocellular carcinoma.
- Published in:
- Clinical & Molecular Hepatology, 2012, v. 18, n. 3, p. 330, doi. 10.3350/cmh.2012.18.3.330
- By:
- Publication type:
- Article
Adenosquamous carcinoma of the liver.
- Published in:
- Clinical & Molecular Hepatology, 2012, v. 18, n. 3, p. 326, doi. 10.3350/cmh.2012.18.3.326
- By:
- Publication type:
- Article
Cyclooxygenase-2 and vascular endothelial growth factor in chronic hepatitis, cirrhosis and hepatocellular carcinoma.
- Published in:
- Clinical & Molecular Hepatology, 2012, v. 18, n. 3, p. 287, doi. 10.3350/cmh.2012.18.3.287
- By:
- Publication type:
- Article
Spinal cord injury after conducting transcatheter arte-rial chemoembolization for costal metastasis of hepato-cellular carcinoma.
- Published in:
- Clinical & Molecular Hepatology, 2012, v. 18, n. 3, p. 316, doi. 10.3350/cmh.2012.18.3.316
- By:
- Publication type:
- Article
Type and cause of liver disease in Korea: single-center experience, 2005-2010.
- Published in:
- Clinical & Molecular Hepatology, 2012, v. 18, n. 3, p. 309, doi. 10.3350/cmh.2012.18.3.309
- By:
- Publication type:
- Article
Thrombocytopenia represents a risk for deterioration of liver function after radiofrequency ablation in patients with hepatocellular carcinoma.
- Published in:
- Clinical & Molecular Hepatology, 2012, v. 18, n. 3, p. 302, doi. 10.3350/cmh.2012.18.3.302
- By:
- Publication type:
- Article
Association between apolipoprotein E genotype, chronic liver disease, and hepatitis B virus.
- Published in:
- Clinical & Molecular Hepatology, 2012, v. 18, n. 3, p. 295, doi. 10.3350/cmh.2012.18.3.295
- By:
- Publication type:
- Article
A case of necrotizing pancreatitis subsequent to trans-catheter arterial chemoembolization in a patient with hepatocellular carcinoma.
- Published in:
- Clinical & Molecular Hepatology, 2012, v. 18, n. 3, p. 321, doi. 10.3350/cmh.2012.18.3.321
- By:
- Publication type:
- Article
Enhanced A-FABP expression in visceral fat: potential contributor to the progression of NASH.
- Published in:
- Clinical & Molecular Hepatology, 2012, v. 18, n. 3, p. 279, doi. 10.3350/cmh.2012.18.3.279
- By:
- Publication type:
- Article
A reduced dose of ribavirin does not influence the viro-logie response during pegylated interferon alpha-2b and ribavirin combination therapy in patients with gen-otype 1 chronic hepatitis C.
- Published in:
- Clinical & Molecular Hepatology, 2012, v. 18, n. 3, p. 272, doi. 10.3350/cmh.2012.18.3.272
- By:
- Publication type:
- Article
Impact of ribavirin dose reduction during treatment in chronic hepatitis C genotype 1 patients.
- Published in:
- Clinical & Molecular Hepatology, 2012, v. 18, n. 3, p. 268, doi. 10.3350/cmh.2012.18.3.268
- By:
- Publication type:
- Article
Changes of guidelines diagnosing hepatocellular carcinoma during the last ten-year period.
- Published in:
- Clinical & Molecular Hepatology, 2012, v. 18, n. 3, p. 258, doi. 10.3350/cmh.2012.18.3.258
- By:
- Publication type:
- Article
Drug-induced liver injury: present and future.
- Published in:
- Clinical & Molecular Hepatology, 2012, v. 18, n. 3, p. 249, doi. 10.3350/cmh.2012.18.3.249
- By:
- Publication type:
- Article